About Englewood Hospital and Medical Center

News

2012 Press Releases

 

Englewood Hospital Introduces Advanced Technology, New to Fight Against Breast Cancer

Molecular Breast Imaging Produces More Accurate, Detailed Results

(Englewood, NJ, November 27, 2012) – Englewood Hospital and Medical Center is now equipped with a Molecular Breast Imaging (MBI) system, a revolutionary new diagnostic tool designed to improve the diagnosis and treatment of early stage breast cancer in women with dense breast tissue or patients who are considered high-risk. This device is the first commercially available, FDA-approved technology of its kind, developed to provide patients with a better treatment plan and more comfortable exam.

“This advanced technology enhances our full-suite of breast imaging equipment and is shown to produce more accurate, detailed results,” said Mindy Goldfischer, MD, Chief of Breast Imaging at Englewood Hospital and Medical Center. “The new system will allow our team to continue to work through the process of diagnosing and treating patients more effectively and efficiently.”

A study from the Mayo Clinic suggests MBI has superior sensitivity, detecting three times as many cancers in patients with dense breasts than mammography.

“While MBI is not a substitute for mammography, we can now use it in conjunction with traditional breast imaging,” explained Dr. Goldfischer. “This enhances our ability to find tumors in patients with dense breasts.”

Dense breast tissue and tumors both appear white on a mammogram, making it more difficult for radiologists to see the suspicious areas of the breast. MBI is specifically developed for patients with dense breasts, whose cancers may go undetected with traditional x-ray.

MBI also provides patients with a less painful procedure, thanks to its innovative design. Patients can expect a more comfortable experience, as it only requires gentle breast compression. Images are also immediately available for interpretation, helping to eliminate the stress and anxiety that comes with waiting for results.

Others who may benefit from MBI include women who have a family history of breast cancer, those who have tested positive for the BRCA1 and BRCA2 gene or patients who cannot undergo MRI.

To determine if you might be a candidate for MBI, call (201)-894-3202 and schedule an appointment at The Leslie Simon Breast Care and Cytodiagnosis Center at Englewood Hospital and Medical Center.

 
About Englewood Hospital and Medical Center
 
Englewood Hospital and Medical Center provides the highest level of compassionate, patient care and safety through a broad range of advanced clinical programs, treatments and diagnostic services. It is renowned for its bloodless medicine and surgery program, cardiac and vascular programs and its leadership in breast care, oncology and joint replacement services. Through its affiliation with the Mount Sinai School of Medicine and the Mount Sinai Consortium for Graduate Medical Education, this acute-care and community teaching hospital trains medical residents in many disciplines, including internal medicine, critical care medicine, surgery, pediatrics, podiatry, and pathology.   Additionally, many members of Englewood Hospital’s medical staff serve as faculty at Mount Sinai. Englewood Hospital has earned numerous accreditations from the Joint Commission and other organizations and is among the four percent of hospitals nationwide honored with the prestigious Magnet nursing award, a distinction that has been earned three times by its nursing staff.